Insider Trading activities at Bioadaptives, Inc. (BDPT)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Bioadaptives, Inc. (BDPT) since 2013 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Bioadaptives, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1575142.

Total stock buying since 2013: $20,625.
Total stock sales since 2013: $40,000.
Total stock option exercises since 2013: $0.


4 insiders reported insider trading activities at Bioadaptives, Inc. (BDPT):
Insider trading activities of Dissanayake Gimhana Sasanka
Insider trading activities of Chiang Richard
Insider trading activities of Epling Barry
Insider trading activities of Ferris Holding Inc.

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Bioadaptives, Inc. (BDPT).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2024 125,000 $10,625 0 $0 0 $0
2013 83,334 $10,000 10,000,000 $40,000 0 $0

Table 2. Monthly summary of insider trading at Bioadaptives, Inc. (BDPT).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2024-11 125,000 $10,625 0 $0 0 $0
2013-10 83,334 $10,000 0 $0 0 $0
2013-06 0 $0 10,000,000 $40,000 0 $0

Table 3. Detailed insider trading at Bioadaptives, Inc. (BDPT)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2024-11-01 Dissanayake Gimhana Sasanka Buy 125,000 .09 10,625
2013-10-01 Ferris Holding Inc. Buy 41,667 .12 5,000
2013-10-01 Epling Barry Buy 41,667 .12 5,000
2013-06-21 Chiang Richard Sale 10,000,000 .00 40,000

Insider trading activities including stock purchases, stock sales, and option exercises of BDPT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Bioadaptives, Inc. (symbol BDPT, CIK number 1575142) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.